Published 2015
| Version v1
Publication
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards
Description
SSc is clinically and aetiopathogenically heterogeneous. Consensus standards for more uniform trial design and selection of outcome measures are needed. The objective of this study was to develop evidence-based points to consider (PTCs) for future clinical trials in SSc.
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/812648
- URN
- urn:oai:iris.unige.it:11567/812648
Origin repository
- Origin repository
- UNIGE